SCHEMBL4318993

SCHEMBL4318993

CCc1cc2c(cc1O)Oc1cc(O)c(CC)cc1C21OC(=O)c2ccc(C(=O)O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.43
MAPT P10636 4/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
HTT P42858 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
SMAD3 P84022 1/20 0.43
PRMT1 Q99873 1/20 0.43
ACE2 Q9BYF1 1/20 0.43
LMNA P02545 3/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.42
PKM P14618 1/20 0.42
CYP3A4 P08684 1/20 0.41
GSTP1 P09211 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4323243 0.91 FTO (0.47) FTOMAPTMEN1KMT2AHTT
SCHEMBL2859711 0.89 FTO (0.42) FTOMAPTMEN1KMT2AHTT
SCHEMBL3688701 0.87 MAPT (0.39) FTOMAPTMEN1KMT2AHTT
SCHEMBL3656489 0.87 FTO (0.44) FTOMAPTMEN1KMT2AHTT
Bromide SCHEMBL23115511 0.86 FTO (0.43) FTOMAPTMEN1KMT2AHTT
SCHEMBL3685151 0.85 MEN1 (0.40) FTOMAPTMEN1KMT2AHTT
SCHEMBL31091444 0.85 FTO (0.44) FTOMAPTMEN1KMT2AHTT
SCHEMBL29613031 0.85 FTO (0.44) FTOMAPTMEN1KMT2AHTT
SCHEMBL4062067 0.85 FTO (0.44) FTOMAPTMEN1KMT2AHTT
SCHEMBL7610486 0.84 HTT (0.46) FTOMAPTMEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507395-B2 Methods of using fluorescent pH indicators for intracellular assays MDS ANALYTICAL TECHNOLOGIES (US) INC. (US) 2009-03-24 US disclosed
US-20050136503-A1 Fluorescent pH indicators for intracellular assays MOLECULAR DEVICES, INC. 2005-06-23 US disclosed
US-6800765-B2 COMPOUND FOR USE AS DIAGNOSTIC TOOL IN THE DETERMINATION OF HYDROGEN ION CONCENTRATION IN FLUIDS MOLECULAR DEVICES CORPORATION 2004-10-05 US disclosed
US-20030068668-A1 Fluorescent pH indicators for intracellular assays MOLECULAR DEVICES, INC. 2003-04-10 US disclosed
EP-1281712-A1 Fluorescent pH indicators for intracellular assays Molecular Devices Corporation (US) 2003-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030068668-A1 Fluorescent pH indicators for intracellular assays CHERP, GOT1, NSF FTO 2752/4885MAPT 1678/4885MEN1 1765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.